Roivant Sciences (ROIV) Invested Capital (2020 - 2026)

Roivant Sciences has reported Invested Capital for 7 years, with the latest figure at $5.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 12.9% year-over-year to $5.3 billion; the trailing twelve-month figure through Mar 2026 stood at $5.3 billion (up 12.9% YoY), and the FY2026 full-year result was $5.3 billion, up 12.9% from the prior year.
• Invested Capital for Q1 2026 stood at $5.3 billion, up from $5.0 billion in the prior quarter.
• The five-year high for Invested Capital was $7.0 billion in Q4 2023, with the low at $1.7 billion in Q3 2023.
• Historically, Invested Capital has averaged $4.1 billion across 5 years, with a median of $4.8 billion in 2025.
• Annual changes were most pronounced in 2023 — Invested Capital surged 287.73% — and 2025, when it plunged 31.86%.
• Roivant Sciences' Invested Capital stood at $1.8 billion in 2022, then surged by 287.73% to $7.0 billion in 2023, then dropped by 20.78% to $5.5 billion in 2024, then dropped by 10.15% to $5.0 billion in 2025, then grew by 6.4% to $5.3 billion in 2026.
• The last three Invested Capital figures came in at $5.3 billion (Q1 2026), $5.0 billion (Q4 2025), and $4.8 billion (Q3 2025), per Business Quant data.